About Vera Therapeutics
Vera Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with immunological diseases. Its lead product candidate, atacicept, is a fully humanized TACI-Fc fusion protein that inhibits both BAFF and APRIL, self-administered as a subcutaneous injection, and is being evaluated for IgA nephropathy (IgAN) and other autoimmune kidney diseases. The company is also developing MAU868 for BK viremia and VT-109 for B cell-mediated autoimmune diseases.
Company details
Funding
Total raised
$197M
Last stage
Public
Investors
Founders
Marshall Fordyce
Physician and biotech executive. Founded Vera Therapeutics in 2016. Previously at Gilead Sciences. Holds an M.D. from Harvard Medical School.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.